| scholarly article | Q13442814 |
| editorial | Q871232 |
| P50 | author | Graham R. V. Hughes | Q73300356 |
| P2860 | cites work | Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant | Q33478061 |
| The clotting defect in SLE. | Q33481801 | ||
| Thrombosis in patients with the lupus anticoagulant | Q33486691 | ||
| THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS DESPITE CIRCULATING ANTICOAGULANTS | Q34540619 | ||
| Pulmonary hypertension in systemic lupus erythematosus. | Q34995801 | ||
| Letter: Aetiology of Jamaican neuropathy | Q39315747 | ||
| Recurrent Venous Thrombosis with a “Lupus” Coagulation Inhibitor in the Absence of Systemic Lupus | Q40511161 | ||
| Central nervous system lupus--diagnosis and treatment | Q71271677 | ||
| Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas | Q71655869 | ||
| Possible relationship between lupus inhibitor and recurrent abortion in young women | Q72429038 | ||
| Arterial thrombosis, intrauterine death and "lupus" antiocoagulant: detection of immunoglobulin interfering with prostacyclin formation | Q72451284 | ||
| Hypergammaglobulinemia, circulating anticoagulant, and biologic false positive Wassermann reaction; a study in two cases | Q74457175 | ||
| Monoclonal lupus autoantibodies | Q85701856 | ||
| P433 | issue | 6399 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | abortion | Q8452 |
| anticoagulant | Q215118 | ||
| thrombosis | Q261327 | ||
| anticoagulation | Q63279445 | ||
| P304 | page(s) | 1088-9 | |
| P577 | publication date | 1983-10-15 | |
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | Thrombosis, abortion, cerebral disease, and the lupus anticoagulant | |
| P478 | volume | 287 |
| Q95359130 | Q95359130 |
| Q89835837 | "Non-criteria" antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort |
| Q35574348 | A Cutaneous Manifestation of Antiphospholipid Antibody Syndrome |
| Q78430741 | A blinding combination |
| Q51160259 | A case of catastrophic antiphospholipid syndrome, which presented an acute interstitial pneumonia-like image on chest CT scan |
| Q69737010 | A common anti-cardiolipin antibody idiotype in autoimmune disease: identification using a mouse monoclonal antibody directed against a naturally-occurring anti-phospholipid antibody |
| Q33501922 | A patient with mixed collagen disease, antiphospholipid syndrome and Sjögren syndrome |
| Q40358418 | A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study). |
| Q37232102 | ACP Broadsheet no 136: February 1993. Detection and importance of anticardiolipin antibodies |
| Q40494782 | Accelerated hypertension and nephroangiosclerosis associated with antiphospholipid syndrome. Report of two cases and review of the literature |
| Q46903232 | Acute and fulminant Budd-Chiari syndrome in a well-anticoagulated patient with primary antiphospholipid syndrome |
| Q36490337 | Acute manifestations of autoimmune connective tissue diseases |
| Q34498392 | Acute myocardial infarction in young adults: causes and management |
| Q33391137 | Addison's disease, hypertension, renal and hepatic microthrombosis in 'primary' antiphospholipid syndrome |
| Q24795768 | Adrenal failure followed by status epilepticus and hemolytic anemia in primary antiphospholipid syndrome |
| Q47957644 | An Overview of Thrombophilia and Associated Laboratory Testing |
| Q64996302 | An Unusual Case of Antiphospholipid Syndrome Presenting as Chorea. |
| Q35867670 | Anaesthesia and the antiphospholipid syndrome: a review of 20 obstetric patients |
| Q92639094 | Anaesthetic considerations for patients with antiphospholipid syndrome undergoing non-cardiac surgery |
| Q43901099 | Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients |
| Q35638142 | Annexin A5 polymorphism (-1C-->T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome |
| Q77326060 | Annexin V is critical in the maintenance of murine placental integrity |
| Q71563308 | Anti phospholipid syndrome |
| Q46941158 | Anti-cardiolipin antibodies in ischaemic heart disease. |
| Q47958994 | Anti-phospholipid syndrome: Current opinion on mechanisms involved, laboratory characterization and diagnostic aspects |
| Q33346329 | Antibodies to anionic phospholipids and anti-beta2-GPI: association with thrombosis and thrombocytopenia in systemic lupus erythematosus |
| Q69874910 | Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events |
| Q46796993 | Antibodies to glutamate receptor subtype 3 (GluR3) are found in some patients suffering from epilepsy as the main disease, but not in patients whose epilepsy accompanies antiphospholipid syndrome or Sneddon's syndrome |
| Q47702901 | Antibody specificity and related clinical features in antiphospholipid syndrome |
| Q39273389 | Antibody to phosphatidylethanolamine in a patient with lupus anticoagulant and thrombosis |
| Q71691168 | Anticardiolipin antibodies and acute myocardial infarction in non-systemic lupus erythmatosus patients: a controlled prospective study |
| Q50895197 | Anticardiolipin antibodies and giant cell arteritis: a prospective, multicenter case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes |
| Q69870521 | Anticardiolipin antibodies in Guillain-Barré syndrome |
| Q69019103 | Anticardiolipin antibodies in a case of neuro-Behçet with superior vena caval occlusion |
| Q35719544 | Anticardiolipin antibody |
| Q33556284 | Anticardiolipin antibody, recurrent thrombosis, and warfarin withdrawal |
| Q33561408 | Anticardiolipin versus lupus anticoagulant tests: no final judgment |
| Q36879113 | Anticoagulation in management of antiphospholipid antibody syndrome in pregnancy |
| Q67886354 | Antiendothelial Cell Antibodies in Patients with the Antiphospholipid Syndrome |
| Q52008896 | Antinuclear autoantibodies, complement level, hypergammaglobulinemia and spontaneous intrauterine hematoma in pregnant women. |
| Q33893371 | Antiphospholipid (Hughes) syndrome in systemic lupus erythematosus |
| Q33384580 | Antiphospholipid (Hughes) syndrome: beyond pregnancy morbidity and thrombosis |
| Q64074958 | Antiphospholipid Antibodies Overlapping in Isolated Neurological Syndrome and Multiple Sclerosis: Neurobiological Insights and Diagnostic Challenges |
| Q35177113 | Antiphospholipid Antibodies: Method of Detection |
| Q90312460 | Antiphospholipid Syndrome and Kidney Involvement: New Insights |
| Q59808719 | Antiphospholipid Syndrome and the Neurologist: From Pathogenesis to Therapy |
| Q35756040 | Antiphospholipid Syndrome during pregnancy: the state of the art |
| Q33416855 | Antiphospholipid antibodies and recurrent pregnancy loss |
| Q69920926 | Antiphospholipid antibodies and thrombosis |
| Q72567741 | Antiphospholipid antibodies in acute Guillain-Barré syndrome |
| Q33567640 | Antiphospholipid antibodies in homozygous sickle cell disease |
| Q33365768 | Antiphospholipid antibodies in mixed connective tissue disease. |
| Q33406476 | Antiphospholipid antibodies in systemic lupus erythematosus: clinical and laboratory associations in 111 patients |
| Q70213134 | Antiphospholipid antibodies in the aetiology of ischaemic optic neuropathy |
| Q28192380 | Antiphospholipid antibodies in young adults with stroke |
| Q48245672 | Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes |
| Q70755530 | Antiphospholipid antibodies syndrome and cerebral ischemia |
| Q69420367 | Antiphospholipid antibodies, thrombosis and vasculitis. Proceedings of a symposium. London, 16th December 1988 |
| Q40559210 | Antiphospholipid antibodies. A marker for thrombosis and recurrent abortion |
| Q35104711 | Antiphospholipid antibodies: discovery, definitions, detection and disease |
| Q48448846 | Antiphospholipid antibodies: pinning risk on a moving target |
| Q42778868 | Antiphospholipid antibodies: which and when? |
| Q41442948 | Antiphospholipid antibody associated thrombosis: a consensus for treatment? |
| Q79721356 | Antiphospholipid antibody syndrome presenting with disseminated bleeding and spinal subdural hemorrhage |
| Q35554909 | Antiphospholipid antibody tests: spreading the net |
| Q72611389 | Antiphospholipid syndrome |
| Q38841201 | Antiphospholipid syndrome (APS) revisited: Would migraine headaches be included in future classification criteria? |
| Q28182092 | Antiphospholipid syndrome and recurrent miscarriages |
| Q33499667 | Antiphospholipid syndrome and the skin |
| Q37045158 | Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview |
| Q73069266 | Antiphospholipid syndrome in pregnancy. Obstetric concerns and treatment |
| Q34799967 | Antiphospholipid syndrome presenting as episodic limb ischaemia |
| Q38294180 | Antiphospholipid syndrome: 30 years and our contribution |
| Q39066464 | Antiphospholipid syndrome: A diagnostic challenge |
| Q33561642 | Antiphospholipid syndrome: linking many specialties |
| Q35114246 | Antiphospholipid syndrome: why and how should we make the diagnosis? |
| Q70280146 | Arterial occlusion causing large bowel infarction--a reflection of clotting diathesis in SLE |
| Q28396086 | Assessing phospholipase A2 activity toward cardiolipin by mass spectrometry |
| Q46431011 | Association of anticardiolipin antibody and C677T in methylenetetrahydrofolate reductase mutation in women with recurrent spontaneous abortions: a new path to thrombophilia? |
| Q71775354 | Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus |
| Q33338788 | Association of beta2-glycoprotein I IgG and IgM antibodies with thrombosis and thrombocytopenia. |
| Q74821714 | Asymptomatic vaso-occlusive retinopathy in Hughes' syndrome |
| Q34551369 | Autoantibodies in lupus and its variants: experience in 1000 patients. |
| Q34299389 | Autoantibodies in the diagnosis of systemicrheumatic diseases |
| Q43408615 | Autoimmune aberration in sudden sensorineural hearing loss: association with anti-cardiolipin antibodies |
| Q47579053 | Autonomic neuropathy-in its many guises-as the initial manifestation of the antiphospholipid syndrome |
| Q54483428 | Beta2GP-I in the anti phospholipid (Hughes') syndrome--from a cofactor to an autoantigen--from induction to prevention of antiphospholipid syndrome. |
| Q36413522 | Bilateral Knee Pain Associated with Bone Infarction in a Patient with Behcet's Disease |
| Q38237932 | Both IgG and IgM anti-beta2 glycoprotein I antibodies assays are clinically useful to the antiphospholipid syndrome diagnosis |
| Q33567403 | Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients |
| Q79368321 | Cardiac valvular disease in patients with systemic lupus erythematosus. Relationship with anticardiolipin antibodies |
| Q48295399 | Cardioembolic caudate infarction as a cause of hemichorea in lupus anticoagulant syndrome |
| Q37115889 | Cardiolipin is a normal component of human plasma lipoproteins |
| Q72106161 | Cardiolipin, coagulation, co-factors and connective tissue disease |
| Q35625240 | Central nervous system lupus: a clinical approach to therapy |
| Q34577009 | Central retinal vein occlusion and thrombophilia |
| Q33561245 | Cerebellar ataxia in systemic lupus erythematosus: three case reports |
| Q33332894 | Cerebral blood flow and glucose metabolism in multi-infarct-dementia related to primary antiphospholipid antibody syndrome |
| Q35625236 | Cerebral haemostasis and antiphospholipid antibodies |
| Q33396957 | Chorea in primary antiphospholipid syndrome is associated with rheumatic fever |
| Q33349144 | Circulating lupus coagulation inhibitor in two sisters, one with disseminated lupus erythematosus and the other with immunologic thrombocytopenic purpura |
| Q70280157 | Circulating lupus type anticoagulant and pulmonary hypertension associated with mixed connective tissue disease |
| Q40529762 | Clinical and therapeutic aspects of the antiphospholipid syndrome |
| Q33404418 | Clinical manifestations and anti-phospholipid antibodies in 712 patients with systemic lupus erythematosus: evaluation of two diagnostic assays |
| Q33497591 | Clinical manifestations of the aPL syndrome |
| Q33359257 | Clinical spectrum of males with primary antiphospholipid syndrome and systemic lupus erythematosus: a comparative study of 73 patients |
| Q42715166 | Covalent attachment of functionalized cardiolipin on a biosensor gold surface allows repetitive measurements of anticardiolipin antibodies in serum |
| Q33403517 | Crosstalk between Platelets and the Immune System: Old Systems with New Discoveries |
| Q40841563 | Current insights into the "antiphospholipid" syndrome: clinical, immunological, and molecular aspects |
| Q72825269 | Current understanding of systemic lupus erythematosus |
| Q41375760 | Cutaneous manifestations of Hughes syndrome occurring in the context of lupus erythematosus |
| Q74263564 | Detection of 'antiphospholipid' antibodies: a single chromogenic assay of thrombin generation sensitively detects lupus anticoagulants, anticardiolipin antibodies, plus antibodies binding beta(2)-glycoprotein I and prothrombin |
| Q52281870 | Detection of cerebral microembolic signals by transcranial Doppler may be a useful part of the equation in determining stroke risk in patients with antiphospholipid antibody syndrome. |
| Q35705938 | Detection of lupus anticoagulant in patients attending an anticoagulation clinic |
| Q67276140 | Detection of lupus like anticoagulant: current laboratory practice in the United Kingdom. The Lupus Anticoagulant Working Party |
| Q33477702 | Diagnosis and treatment of recurrent venous thromboembolism |
| Q36577371 | Diagnosis of antiphospholipid syndrome |
| Q31113892 | Differential diagnosis of multiple sclerosis |
| Q33557343 | Disseminated intravascular coagulation, antiphospholipid antibodies, and ischaemic necrosis of extremities |
| Q33330002 | Do antibodies to beta2-glycoprotein 1 contribute to the better characterization of the antiphospholipid syndrome? |
| Q39697198 | Duke-Elder lecture. Retinal arteritis, retinal vasculitis and autoimmune retinal vasculitis |
| Q45902619 | Effects of ionic strength, temperature and conformation on affinity interactions of β₂-glycoprotein I monitored by capillary electrophoresis. |
| Q48093757 | Elevated Serum Level of HMGB1 in Patients with the Antiphospholipid Syndrome. |
| Q86450783 | Elevated plasminogen activator inhibitor type-1 (PAI-1) as contributing factor in pathogenesis of hypercoagulable state in antiphospholipid syndrome |
| Q36581666 | Endocrinologic manifestations of the antiphospholipid syndrome |
| Q33356831 | Endothelium activation in the anti-phospholipid syndrome |
| Q84312482 | Estimation of the amount of β2-glycoprotein I adsorbed at the inner surface of fused silica capillaries after acidic, neutral and alkaline pretreatment |
| Q35709692 | Evaluating the conformation of recombinant domain I of β(2)-glycoprotein I and its interaction with human monoclonal antibodies |
| Q92146829 | Evaluation of the sensitivity and specificity of a novel line immunoassay for the detection of criteria and non-criteria antiphospholipid antibodies in comparison to established ELISAs |
| Q43446086 | Expression of apoptosis in placenta of experimental antiphospholipid syndrome mouse. |
| Q35760150 | Factor XII autoantibodies as a novel marker for thrombosis and adverse obstetric history in patients with systemic lupus erythematosus |
| Q36896565 | Fatal cardiac failure due to myocardial microthrombi in systemic lupus erythematosus |
| Q47208773 | Frequency of psychological alterations in primary antiphospholipid syndrome: preliminary study |
| Q70510212 | Further immunological studies of sera containing anti-mitochondrial antibodies, type M 5 |
| Q67783001 | Guidelines on testing for the lupus anticoagulant. Lupus Anticoagulant Working Party on behalf of the BCSH Haemostasis and Thrombosis Task Force |
| Q33563788 | Haemostatic factors associated with vascular thrombosis in patients with systemic lupus erythematosus and the lupus anticoagulant |
| Q48452288 | Heparin, antiphospholipid antibodies and the brain |
| Q72567738 | Hepatic veno-occlusive disease due to toxic alkaloid herbal tea |
| Q67911740 | High Prevalence of Significant Heart Valve Lesions in Patients with the 'Primary' Antiphospholipid Syndrome |
| Q68134484 | High aortic occlusion associated with lupus anti-coagulant |
| Q68005070 | Histopathological findings in a case of systemic lupus erythematosus-associated anti-phospholipid syndrome |
| Q46115743 | Hospital based prospective longitudinal clinical and immunologic study of 179 patients of primary anti-phospholipid syndrome |
| Q33374874 | Hughes Syndrome: the antiphospholipid syndrome--a clinical overview |
| Q37101366 | Hughes syndrome (the antiphospholipid syndrome): 25 years old. |
| Q33393146 | Hughes syndrome (the antiphospholipid syndrome): a disease of our time |
| Q38261156 | Hughes syndrome and multiple sclerosis. |
| Q48083403 | Hughes syndrome/APS. 30 years on, what have we learnt? Opening talk at the 14th International Congress on antiphospholipid antibodies Rio de Janiero, October 2013. |
| Q33448386 | Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes |
| Q79157095 | In vivo characterization of bioconjugate B cell toleragens with specificity for autoantibodies in antiphospholipid syndrome |
| Q69264400 | Inadequate periods of anticoagulation in the 'lupus anticoagulant syndrome'--a case report |
| Q36081533 | Increased thromboembolic incidence in anti-cardiolipin-positive patients with malignancy |
| Q33387765 | Influence of gender on the clinical and laboratory spectra of patients with primary antiphospholipid syndrome |
| Q35711767 | Influenza vaccination can induce new-onset anticardiolipins but not β2-glycoprotein-I antibodies among patients with systemic lupus erythematosus |
| Q33564078 | Inhibitory effects of anticardiolipin antibodies on lymphocyte proliferation and neutrophil phagocytosis. |
| Q46938640 | Initial cutaneous manifestations associated with histopathological leukocytoclastic vasculitis in two patients with antiphospholipid antibody syndrome |
| Q71834020 | Intracardiac thrombi associated with antiphospholipid antibodies |
| Q33999868 | Intracardiac thrombosis, phospholipid antibodies, and two-chambered right ventricle |
| Q38661648 | Is clubbing a feature of the anti-phospholipid antibody syndrome? |
| Q36458164 | Laboratory diagnosis and management challenges in the antiphospholipid syndrome |
| Q44066495 | Localized cutaneous necrosis associated with the antiphospholipid syndrome |
| Q34057664 | Long-term follow-up of ischaemic retinopathy in the antiphospholipid syndrome with lupus-like disease |
| Q34532993 | Lower cranial nerve palsy, aseptic meningitis and hydrocephalus: unusual presentation of primary antiphospholipid syndrome |
| Q72898006 | Lower limb ischaemia in primary antiphospholipid syndrome |
| Q39849377 | Lupus anticoagulant and pregnancy |
| Q33446982 | Lupus anticoagulant associated syndrome in benign and malignant systemic disease |
| Q34499518 | Lupus vasculitis: differential diagnosis with antiphospholipid syndrome |
| Q36364726 | Lymphocytic thrombophilic arteritis induced by minocycline. |
| Q45913321 | Management of phenytoin-induced gingival enlargement in a patient with antiphospholipid antibody syndrome: A rare case report. |
| Q61839220 | Maternal immune responses to the fetus in early pregnancy and recurrent miscarriage |
| Q36728230 | Meningismus, fever and macular rash as presenting features of the primary antiphospholipid syndrome? |
| Q37111561 | Methods for detecting lupus anticoagulants and their relation to thrombosis and miscarriage in patients with systemic lupus erythematosus |
| Q35075610 | Migraine, memory loss, and "multiple sclerosis ". Neurological features of the antiphospholipid (Hughes') syndrome |
| Q57272263 | Migraineurs show a high prevalence of antiphospholipid antibodies |
| Q40558504 | Models for central nervous system complications of antiphospholipid syndrome |
| Q34534532 | Multiple steno-obstructive vascular lesions and femoral superficial artery dissection in a young Caucasian male with antiphospholipid syndrome |
| Q38753531 | Musculoskeletal manifestations of the antiphospholipid syndrome |
| Q37631529 | NK cells, autoantibodies, and immunologic infertility: a complex interplay |
| Q44753483 | Neonatal lupus erythematosus, multiple thromboses, and monoarthritis in a family with Ro antibody |
| Q38436403 | Neuropsychiatric presentations of antiphospholipid antibodies. |
| Q37481227 | New potential therapies for the treatment of antiphospholipid syndrome |
| Q36226618 | No evidence of misdiagnosis in patients with multiple sclerosis and repeated positive anticardiolipin antibody testing based on magnetic resonance imaging and long term follow-up |
| Q33376912 | Novel insights into associations of antibodies against cardiolipin and beta2-glycoprotein I with clinical features of antiphospholipid syndrome |
| Q35535848 | Obstetrical implications of antiphospholipid antibodies |
| Q60441393 | Occlusion du tronc artériel brachio-céphalique associée à un syndrome des antiphospholipides : traitement par angioplastie-stent |
| Q67904830 | Opinions on Treatment of Women With Habitual Abortion Based on Investigations for Blocking Antibody and Autoantibodies |
| Q77796443 | Opposite beta2-glycoprotein I requirement for the binding of infectious and autoimmune antiphospholipid antibodies to cardiolipin liposomes is associated with antibody avidity |
| Q70292559 | Optic neuritis and myelopathy in systemic lupus erythematosus |
| Q36149928 | Orthopaedic manifestations of the antiphospholipid (Hughes) syndrome |
| Q36960917 | Orthopedic involvement in antiphospholipid syndrome |
| Q55506942 | Pathogenesis of Antiphospholipid Syndrome. |
| Q37874026 | Pathological gambling and primary antiphospholipid (Hughes) syndrome: a unique neuropsychiatric association |
| Q34287356 | Pathophysiology of thrombosis and pregnancy morbidity in the antiphospholipid syndrome |
| Q44909458 | Patients' experiences of a diagnosis of Hughes' syndrome |
| Q73332373 | Polyclonal anticardiolipin antibodies purified from sera of patients with active systemic lupus erythematosus induce apoptosis of the cultured glomerular mesangial cells |
| Q33163886 | Postural tachycardia syndrome (POTS) and other autonomic disorders in antiphospholipid (Hughes) syndrome (APS). |
| Q39594752 | Pregnancy in lupus nephritis and related disorders. |
| Q33493247 | Pregnancy outcome in women with antiphospholipid antibodies |
| Q33350168 | Prevalence of anticardiolipin antibodies in subacute cutaneous lupus erythematosus |
| Q36681618 | Prevalence of anticardiolipin antibodies in the elderly British population |
| Q43837495 | Prevalence of antiphospholipid antibodies in psychiatric patients users and non-users of antipsychotics |
| Q58421416 | Prevalence of lupus anticoagulant in patients with cirrhosis: relationship with beta-2-glycoprotein I plasma levels |
| Q86527461 | Prevention of recurrent stroke in patients with systemic lupus erythematosus or lupus anticoagulant |
| Q34674429 | Primary anti-phospholipid antibody syndrome (APS): current concepts |
| Q35351368 | Primary antiphospholipid syndrome presenting as thrombotic microangiopathy: Successful treatment with steroids, plasma exchange and anticoagulants |
| Q41937059 | Primary antiphospholipid syndrome with and without Sneddon's syndrome |
| Q36458145 | Primary systemic vasculitis: treatment of difficult cases |
| Q34354761 | Prognosis in antiphospholipid syndrome |
| Q51773681 | Psychiatric manifestations as a primary symptom in antiphospholipid syndrome. |
| Q48082272 | Queen Anne (1665-1714) and her health |
| Q53399059 | Reactive angioendotheliomatosis as a presenting cutaneous manifestation of Hughes syndrome. |
| Q38160857 | Recent advances in laboratory tests and the significance of autoantibodies to nuclear antigens in systemic rheumatic diseases. |
| Q41582396 | Recognition and management of systemic lupus erythematosus |
| Q36284730 | Recognizing antiphospholipid syndrome. Case report: misdiagnosis delayed treatment. |
| Q31011556 | Recombinant tissue plasminogen activator for the treatment of cutaneous infarctions in antiphospholipid antibody syndrome: a case report |
| Q37292999 | Recurrent atraumatic metatarsal, rib and sacral insufficiency fractures in a woman with the antiphospholipid syndrome |
| Q82752211 | Recurrent intestinal perforations as a presentation of antiphospholipid syndrome |
| Q39201530 | Recurrent thrombosis and anticardiolipin antibodies associated with adenocarcinoma of the lung |
| Q45870986 | Reduced factor XII levels in patients with the antiphospholipid syndrome are associated with antibodies to factor XII. |
| Q50200213 | Relationship Between Fetal Loss and Serum Gonadal Hormones Level in Experimental Antiphospholipid Syndrome Mouse |
| Q33344515 | Relative value of different antiphospholipid antibodies detected in a department of internal medicine: retrospective study of 124 patients |
| Q33562467 | Renal artery thrombosis and hypertension in a 13 year old girl with antiphospholipid syndrome |
| Q86984388 | Renal involvement in antiphospholipid syndrome |
| Q87467570 | Renal involvement in antiphospholipid syndrome |
| Q44641118 | Renal involvement in primary antiphospholipid syndrome and its response to immunosuppressive therapy |
| Q28307709 | Renal manifestations of the antiphospholipid syndrome |
| Q70263818 | Retinal vasculitis |
| Q33706460 | Retinopathy in systemic lupus erythematosus: pathogenesis and approach to therapy |
| Q37704593 | Revisiting the molecular mechanism of neurological manifestations in antiphospholipid syndrome: beyond vascular damage |
| Q33489012 | Role of β2-glycoprotein I in the antiphospholipid antibody binding to endothelial cells |
| Q40668710 | Secular trends of pregnancies in women with inflammatory connective tissue disease |
| Q35867162 | Seizures in primary antiphospholipid syndrome: the relevance of smoking to stroke |
| Q41209320 | Sequences of monoclonal antiphospholipid antibodies: variations on an anti-DNA antibody theme |
| Q24674194 | Seronegative antiphospholipid syndrome |
| Q89453447 | Seronegative antiphospholipid syndrome: refining the value of "non-criteria" antibodies for diagnosis and clinical management |
| Q33488994 | Significance of antibodies to cardiolipin in unselected patients with systemic lupus erythematosus: clinical and laboratory associations |
| Q35617645 | Single-step autoantibody profiling in antiphospholipid syndrome using a multi-line dot assay |
| Q53203652 | Sixth meeting of the European Forum on antiphospholipid antibodies. How to improve the understanding of the antiphospholipid syndrome? |
| Q52868549 | Some historical aspects of skin disease in lupus erythematosus. |
| Q33330250 | Splenectomy for refractory thrombocytopenia in the antiphospholipid syndrome |
| Q64951272 | Study of Antiphospholipid Antibodies in Patients with Arterial Hypertension. |
| Q77926546 | Successful primary angioplasty in Hughes syndrome |
| Q73577379 | Sudden-onset ageusia in the antiphospholipid syndrome |
| Q47636314 | Surgical Interventions for Organ and Limb Ischemia Associated With Primary and Secondary Antiphospholipid Antibody Syndrome With Arterial Involvement |
| Q45876558 | Synthesis of Phospholipid-Protein Conjugates as New Antigens for Autoimmune Antibodies. |
| Q48238011 | Systemic antiphospholipid syndrome |
| Q70263826 | Systemic lupus erythematosus |
| Q24543555 | Systemic lupus erythematosus |
| Q35530248 | Systemic lupus erythematosus and thrombosis |
| Q39756290 | Systemic lupus erythematosus clinical issues |
| Q51035970 | Systemic lupus erythematosus: clinical manifestations and immunological parameters in 194 patients. Subgroup classification of SLE. |
| Q33556000 | Tetraplegia as a presenting feature of systemic lupus erythematosus complicated by pulmonary hypertension. |
| Q33393937 | The 'antiphospholipid syndrome' and the 'lupus anticoagulant'. |
| Q70302590 | The Budd-Chiari syndrome. Possible pathogenetic role of anti-phospholipid antibodies |
| Q39195788 | The anti-phospholipid antibody syndrome in a 77 year old man with digital gangrene |
| Q72818973 | The antiphospholipid syndrome |
| Q38873953 | The antiphospholipid syndrome: from pathophysiology to treatment. |
| Q36840249 | The central nervous system in systemic lupus erythematosus |
| Q77925672 | The clinico-ophthalmological spectrum of antiphospholipid syndrome |
| Q24798707 | The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin |
| Q47825970 | The frequency of anti-beta2-glycoprotein I antibodies is low and these antibodies are associated with pulmonary hypertension in mixed connective tissue disease. |
| Q34680879 | The neuropathology and pathogenesis of systemic lupus erythematosus |
| Q33446848 | The prevalence and clinical associations of the lupus anticoagulant in systemic lupus erythematosus. |
| Q47827238 | The stillbirth scandal. |
| Q33497584 | The syndrome of thrombosis, thrombocytopenia, and recurrent spontaneous abortions associated with antiphospholipid antibodies: Hughes syndrome |
| Q33365607 | The systemic nature of the antiphospholipid syndrome |
| Q37995711 | The use of heparin for preventing miscarriage |
| Q33458487 | Thrombocytopenia and lupus-like anticoagulant in a patient with peripheral vascular disease: response to infusion of prostacyclin |
| Q42378451 | Thrombomodulatory Effect of Anti-B2-Glycoprotein I Antibodies on Crystalline Annexin A5 on Phospholipid Bilayers, as Observed by Atomic Force Microscopy |
| Q61895180 | Thrombose sévère révélant un syndrome des antiphospholipides chez 2 jeunes filles atteintes d’un lupus érythémateux systémique |
| Q28192395 | Transient global amnesia in a patient with high and persistent levels of antiphospholipid antibodies |
| Q39018957 | Transient lupus anticoagulant and fansidar therapy |
| Q33939249 | Transient visual symptoms in systemic lupus erythematosus and antiphospholipid syndrome |
| Q28193706 | Treatment and monitoring of patients with antiphospholipid antibodies and thrombotic history (Hughes syndrome) |
| Q57218066 | Unusual and aggressive thrombotic onset in two children with antiphospholipid-antibody syndrome and systemic lupus erythematosus |
| Q64269789 | Upregulation of ADAMTS‑7 and downregulation of COMP are associated with spontaneous abortion |
| Q35702083 | Vascular disease, thrombosis, and recurrent abortion |
| Q52477266 | [Antiphospholipid antibodies (aPL): detection and clinical significance]. |
| Q84286380 | [Necrotic papules on the abdomen] |
Search more.